Elamipretide (also known as SS-31) is a novel mitochondria-targeting tetrapeptide designed to protect and restore mitochondrial function. By selectively localizing to the inner mitochondrial membrane, Elamipretide stabilizes cardiolipin and improves ATP production, making it a promising candidate in the treatment of mitochondrial diseases, cardiomyopathy, and age-related disorders.
Key Features & Benefits:
-
Mitochondrial Protection: Targets and stabilizes mitochondrial membranes to improve energy production and reduce oxidative stress.
-
Versatile Therapeutic Potential: Explored in clinical research for heart failure, dry AMD, mitochondrial myopathy, and neurodegenerative diseases.
-
High Bioavailability: Designed for systemic delivery with strong cellular penetration.
-
Clinically Studied: Demonstrated safety and efficacy in early-stage clinical trials.
Applications:
-
Mitochondrial Disease Research
-
Cardiology and Neurology Drug Development
-
Anti-aging and Regenerative Medicine
-
Pharmaceutical and Biomedical Research
